3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
18
Unknown
4
Terminated
3
Withdrawn
2
Active not recruiting
2
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Multiple Myeloma
87
Precursor Cell Lymphoblastic Leukemia-Lymphoma
22
Recurrence
16
Burkitt Lymphoma
13
Neoplasms
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Biphenotypic, Acute
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Lung Neoplasms
6
Immunoglobulin Light-chain Amyloidosis
6
Neoplasms, Plasma Cell
5
Leukemia
5
Hodgkin Disease
5
Smoldering Multiple Myeloma
4
Carcinoma, Non-Small-Cell Lung
4
Waldenstrom Macroglobulinemia
3
Triple Negative Breast Neoplasms
3
Prostatic Neoplasms
3
Neoplasm Metastasis
3
Nausea
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Brain Neoplasms
3
Renal Insufficiency
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Ovarian Neoplasms
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell
2
Lymphoma, B-Cell
2
Leukemia, Plasma Cell
2
Interventions
Cyclophosphamide
20
Rituximab
18
obinutuzumab
14
Lenalidomide
14
zanubrutinib
11
fludarabine
10
Bendamustine Hydrochloride
10
Prednisone
8
Magnetic Resonance Spectroscopy
8
Vincristine
7
Doxorubicin
7
Specimen Handling
6
fludarabine phosphate
5
Radiotherapy
4
Biopsy
4
axicabtagene ciloleucel
3
Whole-Body Irradiation
3
tisagenlecleucel
2
polatuzumab vedotin
2
pirtobrutinib
2
loncastuximab tesirine
2
Therapeutics
2
Prednisolone
2
Positron Emission Tomography Computed Tomography
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Leukapheresis
2
Immunotherapy, Adoptive
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Lymphoma, Follicular
×
Dexamethasone
×
Clear all
NCT05849857
2023-11-01
MERLIN
Oslo University Hospital
Phase 2
Recruiting
80 enrolled